1E5G | A:7-68; A:69-126 | SOLUTION STRUCTURE OF CENTRAL CP MODULE PAIR OF A POX VIRUS COMPLEMENT INHIBITOR |
1G40 | A:1-64; A:65-126; A:127-184; A:185-243; B:1-64; B:65-126; B:127-184; B:185-243 | CRYSTAL STRUCTURE OF A COMPLEMENT PROTEIN THAT REGULATES BOTH PATHWAYS OF COMPLEMENT ACTIVATION AND BINDS HEPARAN SULFATE PROTEOGLYCANS |
1G44 | A:1-64; A:65-125; A:127-184; A:185-243; B:1-64; B:65-125; B:127-184; B:185-243; C:1-64; C:65-125; C:127-183; C:185-243 | CRYSTAL STRUCTURE OF A COMPLEMENT CONTROL PROTEIN THAT REGULATES BOTH PATHWAYS OF COMPLEMENT ACTIVATION AND BINDS HEPARAN SULFATE PROTEOGLYCANS |
1RID | A:1-64; A:65-126; A:127-184; A:185-244; B:1-64; B:65-126; B:127-184; B:185-244 | VACCINIA COMPLEMENT PROTEIN IN COMPLEX WITH HEPARIN |
1VVC | A:1-58; A:59-118 | C-TERMINAL HALF OF VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN, NMR, MINIMIZED AVERAGE STRUCTURE |
1VVD | A:1-58; A:59-118 | C-TERMINAL HALF OF VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN, NMR, 21 STRUCTURES |
1VVE | A:1-58; A:59-118 | C-TERMINAL HALF OF VACCINIA VIRUS COMPLEMENT CONTROL PROTEIN, NMR, 21 STRUCTURES |
1Y8E | A:1-64; A:127-184; A:185-244; B:2-64; B:65-126; B:127-184; B:185-244; A:65-126 | VCP:SURAMIN COMPLEX |